Literature DB >> 16245239

Chronic renal failure in male and female rats.

Carla C S Lemos1, Carlos A Mandarim-de-Lacerda, David Dorigo, Terezila M Coimbra, Rachel Bregman.   

Abstract

Gender influences the progression of chronic renal failure (CRF). We studied male (M) and female (F) Wistar rats for 90 days: castrated (CMc,n=7;CFc,n=6) and non castrated controls (CM,n=9;CF,n=6); castrated (CRFMc,n=8; CRFFc,n=6) and non castrated animals submitted to 5/6 nephrectomy (CRFM,n=13;CRFF,n=6). Data are expressed as mean +/-SEM. Proteinuria (PTN) was higher in CRFM (554+/-69 mg/24h) compared to CRFMc (277+/-85 mg/24h), but not in females (CRFF=193+/-20mg/24h, CRFFc= 164+/-71 mg/24h). Mesangial fractional volume increased in all CRF animals. CRF animals showed an increase of glomerular sclerosis index (GSI) and tubulointerstitial damage (TID) but in a smaller proportion in male castrated animals; the opposite occurred with females: castration induced an increase of these parameters. CRF animals showed increased cortical and glomerular fibronectin (FN) rates. Castration decreased glomerular and cortical FN rates in CRFM but not in females. In conclusion, proteinuria was higher in CRFM and probably led to glomerular and interstitial damage, as well as to FN accumulation, castration seems to protect against development of PTN, TID and FN accumulation in males. Castrated female rats presented mesangial expansion, with no changes in PTN, TID and FN rates. It seems that female sex hormones do not protect against renal disease progression, instead, we suggest that male sex hormones lead to acceleration of CRF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16245239

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

Review 1.  The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease.

Authors:  Sebastian Kummer; Gero von Gersdorff; Markus J Kemper; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

2.  Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process.

Authors:  Sugyeong Ha; Ki Wung Chung; Jaewon Lee; Hae Young Chung; Hyung Ryong Moon
Journal:  Arch Pharm Res       Date:  2022-03-25       Impact factor: 4.946

3.  Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.

Authors:  Colby J Vorland; Pamela J Lachcik; Elizabeth A Swallow; Corinne E Metzger; Matthew R Allen; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

4.  17β Estradiol Modulates Perfusion Pressure and Expression of 5-LOX and CYP450 4A in the Isolated Kidney of Metabolic Syndrome Female Rats.

Authors:  A M Zúñiga-Muñoz; V Guarner Lans; E Soria-Castro; E Diaz-Diaz; R Torrico-Lavayen; E Tena-Betancourt; I Pérez-Torres
Journal:  Int J Endocrinol       Date:  2015-09-27       Impact factor: 3.257

5.  Effect of castration on renal glycosaminoglycans and their urinary excretion in male and female rats with chronic renal failure.

Authors:  C C S Lemos; A M F Tovar; M A M Guimarães; R Bregman
Journal:  Braz J Med Biol Res       Date:  2013-08-01       Impact factor: 2.590

6.  Axl tyrosine kinase protects against tubulo-interstitial apoptosis and progression of renal failure in a murine model of chronic kidney disease and hyperphosphataemia.

Authors:  Gareth D Hyde; Rebecca F Taylor; Nick Ashton; Samantha J Borland; Hon Sing Geoffrey Wu; Andrew P Gilmore; Ann E Canfield
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.